Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain uncertain ...
Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs). The FDA has ...
Electric cars, climate credit schemes, diverse boardrooms and legal weed: How California exports its ideas and policies across the U.S. Newly released photographs from Jeffrey Epstein’s estate do not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback